BIOTECNICA INSTRUMENTS SPA

Biotecnica Instruments SPA specializes in semi-automated clinical chemistry analysers intended for laboratory use. These devices are designed for in vitro diagnostic (IVD) testing, allowing healthcare professionals to measure key biochemical parameters in patient samples, such as glucose, electrolytes, or enzymes. The focus is on streamlining workflows in clinical settings with automated yet flexible systems.

Biotecnica Instruments SPA is based in the United States, which means its devices fall under FDA regulatory jurisdiction. The company’s products are listed in the FDA’s Unique Device Identifier (UDI) database, ensuring traceability and compliance tracking. While the location influences regulatory pathways, individual devices must still meet FDA requirements for classification and market authorization.

Biotecnica Instruments SPA’s devices are classified under FDA’s Class I regulatory category. This classification applies to devices considered to pose the lowest risk to patients and users, often involving minimal potential for harm. Class I devices typically require general controls (e.g., good manufacturing practices) but may not need pre-market approval, depending on their specific design and intended use. The Envoy analyser, for example, aligns with this classification due to its role in routine laboratory diagnostics.

Yes, Biotecnica Instruments SPA’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry assigns a standardized identifier to each device, improving transparency, traceability, and recall management. Listing in the UDI system helps healthcare providers, regulators, and supply chain partners quickly verify product details, compliance status, and manufacturing history—critical for ensuring patient safety and operational efficiency in clinical environments.